67f91f00d12992c1c1358e48 Logo20diasorin No20payoff In20vitro Cmyk

Diasorin

12112 Technology Blvd Suite 130
Austin, TX 78727
United States of America
512-219-8020

More Info on Diasorin

67f91f00d12992c1c1358e48 Logo20diasorin No20payoff In20vitro Cmyk

Sample-to-Customizable Answers for Your Respiratory Testing

   The LIAISON PLEX® System is uniquely designed to provide full flexibility in the customization of syndromic panels and will allow clinical laboratory staff to overcome the constraint of the “one size fits all” approach for infectious disease syndromic diagnostics. This fully automated, easy to use, sample-to answer system has a streamlined workflow and a room-temperature consumable. The operational hands-on time is only two minutes per sample and results are produced in less than two hours.

The LIAISON PLEX® Respiratory Flex Assay is the first assay cleared for use on our new LIAISON PLEX System. Testing for 19 pathogens commonly associated with respiratory infections—including 14 viral and 5 bacterial targets—the LIAISON PLEX Respiratory Flex Assay gives users the choice to process and pay for a specific subset of customized results based on patient needs. Compared to standard panel testing, this method can improve clinical utility while decreasing cost burdens on patients and healthcare systems. Through the application of panel testing, patient care and treatment can be optimized in support of diagnostic stewardship efforts, thus enabling proper patient therapies and reducing costly over-testing.

   Modernize your respiratory testing with sample-to-customizable answer capabilities—discover how the LIAISON PLEX Respiratory Flex Assay will address your lab’s current and future needs while battling the rising cost of patient care.

News

By angellodeco on Adobe Stock
adobestock_114090939
Diasorin announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LIAISON PLEX Gram-Positive Blood Culture Assay, the final syndromic...
June 10, 2025
ID 336482967 | Ai © Irina Foto | Dreamstime.com
dreamstime_xxl_336482967
Diasorin announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the second of its 3 multiplex molecular panels for blood culture pathogen...
April 22, 2025
Photo 323621432 © Aumporn Charicha | Dreamstime.com
dreamstime_xxl_323621432
Simplexa C. auris Direct is a is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument for the direct in vitro qualitative detection of Candida auris DNA...
July 19, 2024
Photo 55304069 © Pleprakaymas | Dreamstime.com
dreamstime_xxl_55304069
It is the second multiplexing molecular diagnostic panel on the LIAISON PLEX to be cleared by the U.S. FDA after the Respiratory Flex Assay, which received clearance in March ...
June 6, 2024
Photo 80935730 © Kittipong Jirasukhanont | Dreamstime.com
dreamstime_xxl_80935730
NxTag Respiratory Pathogen Panel (RPP) v2 is a molecular multiplex panel that detects 21 different pathogens (bacteria, viruses).
May 20, 2024
Illustration 33363933 © Farakos | Dreamstime.com
dreamstime_xxl_33363933
LIAISON PLEX is the new multiplexing platform of the group, together with the LIAISON PLEX Respiratory Panel.
March 5, 2024

Articles

Photo 251854866 © Anlooka | Dreamstime.com
Dreamstime Xxl 251854866
Provides streamlined workflow to detect flu a, flu b, and SARS-CoV-2 viruses in about an hour with minimal hands-on time.
March 21, 2023

Request More Information From Diasorin

By clicking above, I agree to Endeavor Business Media's Terms of Service and consent to receive promotional communications from Endeavor, its affiliates, and partners per its Privacy Notice. I also understand my personal information will be shared with the sponsor of this content, who may contact me about their offerings per their privacy policy. I can unsubscribe anytime.